Recruiting

Nociscan

Sponsor:

Aclarion

Code:

NCT06661850

Conditions

Discogenic Low Back Pain

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Fusion or TDR determined by investigator.

Study Details

Brief summary:

This study is looking into how safe and useful NOCISCAN is. NOCISCAN is a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. Nociscan (instead of 'It') leverages MRS to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. The randomized controlled trial will compare the blinded and unblinded cohorts and their corresponding surgical outcomes with the Nocigram reports, generated prior to treatment, for each patient."

Conditions

Discogenic Low Back Pain

Study ID

NCT06661850

Start date

Jun 11, 2025

Status verified date

Jul, 2026

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Sep 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Subject is a skeletally mature male or female (non-pregnant) aged 18 to 70 years (inclusive);
2. Subject plans to undergo surgical treatment of their discogenic back pain independent of this research protocol;
3. Subject is to be treated with on-label use of FDA-cleared or FDA-approved devices independent of this research protocol;
4. Subject has a diagnosis of discogenic back pain that requires treatment in up to two lumbar levels caused by degenerative disc disease (identified via MRI);
5. Subject has a preoperative Oswestry Disability Questionnaire score ≥35 out of 100 points (35/100);
6. Subject has a VAS back pain score of ≥40mm and that is greater than the worst VAS leg pain score;
7. Subject has failed at least ≥ 6 months of non-operative treatment (for example: physical therapy, bed rest, anti-inflammatory or analgesic medications, chiropractic care, acupuncture, massage therapy or home-directed lumbar exercise programs) OR requires urgent surgical treatment per the investigator;
8. Subject has signed the IRB approved Informed Consent Form; and
9. Subject is psychosocially, mentally and physically able and willing to fully comply with this protocol including adhering to follow-up schedule and requirements and filling out forms.

Exclusion Criteria:

1. Subject has a primary diagnosis of spinal condition other than degenerative disc disease at the involved level (i.e., facet joint pain/SI pain);
2. Subject has had prior lumbar back surgery or intradiscal treatments at any lumbar level (Note: diagnostic provocative or anesthetic discography are not excluded; micro-discectomy, decompression, or laminectomy patients greater than 6 months postop are not excluded);
3. Surgery is planned for more than 2 lumbar levels.
4. Subject has severe spinal canal stenosis as assessed by the Investigator;
5. Subject has a motor strength deficit(s) in lower extremities
6. Subject has a lumbar spine diagnosis, based on radiographic evidence, of clinically relevant lumbar vertebral abnormalities (except Modic end-plate changes, which are not excluded), including:

  • Spondylolisthesis Grade 2 or greater (up to Grade 1 is accepted)
  • Pars fracture, at the involved level
  • Spondylolysis
  • Lumbar scoliosis with a Cobb angle of greater than 15°
  • Evidence of prior fracture or trauma to the L1, L2, L3, L4, or L5 levels in either compression or burst
  • Lumbar kyphosis
7. Subject has radiologic evidence of an uncontained lumbar disc herniation or lumbar disc extrusion.
8. Subject is contraindicated for a standard lumbar MRI exam
9. Women who are currently pregnant (or believe they may be at risk of being or becoming pregnant), or are breast feeding, during the study period when scans will be performed
10. Subject is currently receiving worker's compensation or is involved in in any litigation for personal injury, medical negligence, trauma, or worker's compensation.
11. Subject has a chronic disease (other than degenerative disc disease), chronic pain (other than discogenic low back pain), or psychological dysfunction, which may, in the opinion of the Principal Investigator, compromise a subject's ability to comply with study procedures, and/or may confound data
12. Subject has a BMI > 40

Study Design

Enrollment

300 participants

Anticipated

Interventions and Outcome Measures

Arms

Blinded-to-NOCISCAN

NOCISCAN completed pre-operatively. Investigator will not have access to NOCISCAN result.

Unblinded-to-NOCISCAN

NOCISCAN completed pre-operatively. Investigator will have access to the NOCISCAN result after completing initial treatment plan but before treatment.

Interventions

Fusion or TDR determined by investigator.

The surgical treatment will be decided by the treating investigator based on their clinical judgement.

Primary outcome measure

  • Change in back pain on 100mm Visual Analog Scale (VAS) Pain Assessment [ Time Frame: Baseline to 12 months ]

Central Contacts and Locations

Central contacts

Locations

Todd H. Lanman, M.D Inc

Recruiting

Beverly Hills, California, United States, 90210

Contacts

Principal Investigator:

Todd Lanman, MD

Scripps Health

Recruiting

La Jolla, California, United States, 92037

Contacts

Principal Investigator:

Hani Malone, MD

USC Keck Medical Center

Recruiting

Los Angeles, California, United States, 90033

Contacts

Principal Investigator:

Patrick Hsieh, MD

University of Miami/ Jackson Health System

Recruiting

Miami, Florida, United States, 33136

Contacts

Principal Investigator:

Gregory Basil, MD

Northwestern University

Recruiting

Chicago, Illinois, United States, 60611

Contacts

Principal Investigator:

Alpesh Patel, MD

Endeavor Health

Recruiting

Evanston, Illinois, United States, 60201

Contacts

Principal Investigator:

Michael Musacchio, MD

Advocate Aurora Research Institute

Recruiting

Park Ridge, Illinois, United States, 60068

Contacts

Principal Investigator:

Patrick Sugrue, MD

Johns Hopkins Medicine

Recruiting

Baltimore, Maryland, United States, 21287

Contacts

Principal Investigator:

Daniel Lubelski, MD

Texas Back Institute

Recruiting

Plano, Texas, United States, 75093

Contacts

Principal Investigator:

Alexander Satin, MD

More Information

Sponsor

Aclarion

Last update posted

Jul 24, 2026

Last verified

Jul, 2026

Keywords

  • MR Spectroscopy
  • MRI
  • back pain
  • Nociscan

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-04. This information was provided to ClinicalTrials.gov by Aclarion on 2026-07-24.